Correction to: BMC Gastroenterology (2020) 20:296 https://doi.org/10.1186/s12876-020-01441-6
After publication of this article [1], the authors reported three adjustments:
-
1.
Competing interests: the travel grants were paid by HLW Pharma instead of TEVA Pharma.
-
2.
TGN-units all over the manuscript have to be adjusted from pmol/8 × 105 RBC to pmol/8 × 108 RBC.
-
3.
Some minor textual adjustments.
The original article [1] has been updated.
Reference
Bayoumy AB, van Liere ELSA, Simsek M, et al. Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom. BMC Gastroenterol. 2020;20:296. https://doi.org/10.1186/s12876-020-01441-6.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Bayoumy, A.B., van Liere, E.L.S.A., Simsek, M. et al. Correction to: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom. BMC Gastroenterol 22, 208 (2022). https://doi.org/10.1186/s12876-021-01992-2
Published:
DOI: https://doi.org/10.1186/s12876-021-01992-2